Try our Advanced Search for more refined results
Health - January, 2012
248 articles
- Blue Shield Agrees To Cover Autism Therapy In Calif. Suit
- Chile Fines 2 Pharmacy Chains $38M For Price Fixing
- Micromet Investor Sues To Halt $1.2B Amgen Purchase
- Generic Cancer Drug MDL Tossed In Light Of Mensing
- Omnicare Faces OT Class Action By Technicians, Others
- Enzo, Roche Square Off Over Medical Testing Patent
- How To Lead A Practice Group
- Cadwalader Aids AngioDynamics In $372M Device Maker Buy
- Bayer Seeks to Block Pfizer's Bovine Drug With IP Suit
- Warner Chilcott Targeted Over Sales Reps' OT Pay
- Pfizer Wants Court To Pause Zoloft Birth Defects Suit
- Blue Cross Blasts Aetna's Antitrust Allegations
- AstraZeneca Sues Generics Maker Over Nexium Patents
- Coventry Rips Sanctions Bid In OSF Hospital Merger Fight
- FDA Accused Of Spying On Employee Scientists' Emails
- Ex-Symmetry Medical Workers Consent To Fraud Claims
- J&J, Merck Take Heat Over L'Oreal Sunscreen Patents
- Drug Co. Valeant Walks Away From Bid for Ista
- Kilpatrick Brings Finnegan IP Whiz To Silicon Valley
- Ex-McKesson Chair Asks High Court To Toss Guilty Verdict
- FTC Sues Omnicare To Block $441M PharMerica Merger
- Health Law Can Stand Even Without Mandate: White House
- Teva Unit Recalls Cancer Drug Treanda Over Glass Fragments
- Allergan Targets Hi-Tech Over IP For Glaucoma Generic
- Texas Denied Waiver On Health Reform Premium Rules
- FDA Reopens Comments On Drug Ad Rule In New Study's Wake
- Medtronic Hit With $10M Jury Verdict Over Catheter Patent
- Cooley Partner Takes GC Job At Jazz Pharmaceuticals
- Insurance Watchdog Investigating Lap-Band Centers: Aetna
- 5 Ways To Ramp Up Your Patent Portfolio
- Hospital Group Hid Whistleblower Suit: Investors
- EC Proceeds With Antitrust Probe Of French Drug Co.
- Jury Finds Varian Willfully Infringed Cancer Patent
- Affymetrix Suit Over Illumina Microarray IP Reopened
- AstraZeneca, Lupin Soothe Nexium Patent Fight
- Cordis Sues USPTO For Blocking Stent Re-Exam Subpoenas
- Pfizer Faces ERISA Stock-Drop Suit By Puerto Rico Workers
- Graceway's Ch. 11 Plan Hinges On Asset Sale
- Ex-CDC Official Gets 4 Years For Contract Bribes
- Celgene Snags Cancer Treatment Co. Avila For $350M
- Illumina Rebuffs $5.7B Roche Bid With Poison Pill
- Hospital Groups Clash Over Doc Request In Competition Battle
- Fed. Circ. Lifts Block On Generic Lovenox Sales
- A Health And Welfare Benefit Year In Review
- The Sentry That Guards Against The Tyranny Of Experts
- Ranbaxy Bows To Sweeping Penalties From US
- Sullivan Helps Amgen In $1.2B Micromet Buy
- Founder Of French Silicon Implant Co. Arrested Amid Scandal
- Forest Labs Bribed Study Authors To Boost Celexa: Suit
- Biotech Co. Affymetrix Pays $96M To End Investor Suit
- 4th Circ. Tosses Suit Over FDA-Approved Medtronic Device
- Ex-NY Sen. Espada, Son Deny False Statement Charges
- Cephalon Sues Mylan, Sandoz Again Over Generic Fentora
- State Farm Wins Provider Reimbursement Fight In 11th Circ.
- Celgene, Novartis Chastised Over Cancer Drug Claims
- CPSC Proposes Child-Resistant Packages for Decongestants
- Covidien Makes Deal With Watson To Allow Generic Exalgo
- Takeda Hid Gout, GERD Drug Interactions: Whistleblower
- Texas Abortion Law Opponents Seek 5th Circ. Rehearing
- Planned Parenthood Buys NY Headquarters For $35M
- Fed. Circ. Gives Roche 2nd Shot In Blood Test IP Fight
- Forest Labs Derivative Suit Belongs In Federal Court: Atty
- Biosimilars Law In Limbo
- Ex-HealthSouth CEO Gets 1 Year Dropped From Prison Time
- UK Probes Simplyhealth's $180M Dental Insurance Co. Buy
- Substantial Guidance For The FDA's 510(k) Program
- Roche Launches $5.7B Hostile Bid For Illumina
- Pfizer Triumphs Over Drinkmaker In Viagra Mark Dustup
- Novartis To Settle Sales Reps' OT Claims For $99M
- Canada, Novartis Issue Warning On Blood Pressure Drugs
- Health Group Of The Year: Weil Gotshal & Manges
- APP Settles Patent Row Over Generic Blood Thinner
- Cancer Agency Disliked Nonprofit, Barred Contract Bid: Suit
- EU Lawmakers Call For Tighter Controls On Breast Implants
- Bradley Arant Nabs Winston & Strawn Antitrust Atty
- Judge Cuts Conspiracy Claims Against Cigna, Others
- Ex-Canopy CEO Gets 15 Years For $93M Scheme
- Acura Settles Shareholder Claims Over Acurox For $1.5M
- Generics Cos. Fight Lovenox Injunction In Fed. Circ.
- Drug Co. Watson Grows Asian Presence With Ascent Buy
- CORRECTED: CRA Loses New Protest Over $230M Army Health Contract
- Broker-Dealers Elude BNY Mellon, Wells Fargo In MedCap MDL
- CR Bard, Others Face Onslaught Of Surgical Mesh Suits
- St. Jude Awarded $27M In Vascular Closure Device IP Fight
- Venable Lures 3 IP Experts From Patton Boggs
- Lilly Sues Accord Over Generic Lung Cancer Drug Alimta
- Abbott Sues Generic Maker Over Cholesterol Drug Patent
- Health Group Of The Year: Ropes & Gray
- FDA Delays Decision on Alexza Antipsychotic Treatment
- Sandoz Targeted Over Generic Cancer Drug Fusilev
- Kagan Recusal Arguments Nixed In High Court Health Fight
- FTC To Drop Antitrust Suit Over Lundbeck Heart Defect Drug
- FDA Panel Turns Down Columbia, Watson Preterm Birth Gel
- Meda Sues 2 Cos. Over Generic Nasal Spray Patent
- Wyeth, Cordis Stent Patents Are Invalid, Judge Says
- Fed. Circ. To Probe When Intervening Rights Kick In
- Health Group Of The Year: Covington & Burling
- Braintree, Buyers Settle Generic MiraLax Suit For $17M
- Dems Seek Probe Of Medical Device Cos.
- 11 Deaths Prompt EU Review Of Novartis Drug Gilenya
- The New Ease Of Terminating Section 501(c)(3) Status
- Expert Testimony OK In Miscarriage Drug Suit: Judge
- Genova Targets Kansas Lab Over Autism Test Patent Deal
- Merck Unit, Pamlab Sue Over Generic Metafolin
- Nurses Can Pursue Collective, Class Wage Actions: Judge
- Health Care Group Of The Year: Arnold & Porter
- Charges Against Stryker, Sales Staff Dropped For $15M
- FDA Seeks More Info On Bristol, AstraZeneca Diabetes Drug
- Siemens Devalued HearUSA Stock Ahead Of Takeover: Suit
- Merck Closes Out Canadian Vioxx Claims For Up To $36.5M
- 8 Insurers Settle Over Misleading Health Provider Info
- 4th Circ. Upholds GSK Win In Vaccine Contract Suit
- Pfizer Seeks To Merge 59 Zoloft Birth Defect Suits
- Foley Hoag Adds M&A, Securities Vet in Boston
- Another Look At W-2 Reporting Requirements
- J&J Settles Texas' Risperdal Suit For $158M
- Calif. Appeals Court Gives Hospital Wage Suit Another Shot
- Alnylam Claims Tekmira Infringed RNAi Tech Patents
- Covidien Recalls Chest Surgery Device After Patient Deaths
- Feds Push For 1st Circ. To Reopen FCA Suit Against Pfizer
- Latham Woos Pharma IP Pro From Wilson Sonsini
- Stiefel Can't Shake ERISA, Fraud Claims Over GSK Buy
- Health Group Of The Year: Akin Gump
- Stryker To Pay $15M To End False Marketing Case
- Baker Botts Lures McDermott M&A Pros To Calif. Digs
- Cadwalader Scores Top Dealmaker From Cahill Gordon
- Asian Buyout Firm Takes $100M Stake In DM Healthcare
- 2nd Circ. Quashes Savient Investor's Class Action
- IASIS Wins Sanctions Over Privileged Docs In FCA Case
- GSK Settles Bulk Of Avandia MDL Cases
- Judge Nixes Settlement In Rural/Metro Buyout Suit
- Feds Drop Charges Against Stryker Sales Manager
- Ex-Sanofi Researcher Cops To Trade Secrets Theft
- FDA Fines Red Cross $9.6M For Continued Missteps
- Supreme Court Lets 2 New Biz Owners Join Health Fight
- Fresenius Targets Nostrum's Generic PhosLo GelCaps
- The FDA Crackdown On Health Care Provider Ads
- Olympus Panel Clears KPMG, Ernst & Young In Fraud Probe
- Fed. Circ. Shuts Down Abbott Blood Test Patent Suit
- Wash. Gov., AGs Back Health Care Law In Supreme Court
- Price Uniformity Not Required For Cert.: 7th Circ.
- Burkle Bags Stake In Soho House For Reported $383M
- Merck Unit Sues To Block Teva's Generic Singulair
- Chemed Investors Sue Over Alleged Hospice Scam
- Brain Infection Reports Prompt Boxed Warning On Adcetris
- The 10 Worst Drug/Medical Device Decisions Of 2011
- Fed. Circ. Won't Let Bryan Cave Out Of AIA Patent Case
- McKesson's Bid To Revive Pill Dispenser IP Suit Nixed
- Lilly, 3rd-Party Payors Reach $4.5M Deal In Zyprexa Case
- Stryker Unit Settles Bone Staple Patent Suit
- Bankrupt Hospital Sues Over Malpractice Coverage
- Discovery Bid Heads To Canada In Lantheus Coverage Suit
- Inhibitex Investor Sues To Block $2.5B Bristol-Myers Deal
- CVS To Pay $5M To End FTC's Deceptive Drug Price Claims
- Atty Accused Of Defaming 3M Asks To Toss Case
- Quest Diagnostics Hit With $100M Sex Bias Suit
- PwC, Milliman To Pay $7M To Settle Hospital RICO Claims
- Insurer Tries To Dodge Defending Avastin Distributor
- ITC Staff Sides With Merck In NuvaRing Patent Battle
- Walgreen, Par Schemed To Overcharge For Generics: Suit
- Meritain Accuses Express Scripts Of Client Data Theft
- More Countries Raise Alarm Over Faulty Breast Implants
- Paul Weiss Reps Universal American In $228M APS Buy
- Perrigo Beats Reckitt Unit's Suit Over Generic Mucinex
- FDA Warns J&J Unit Over Insulin Pump Reporting Delays
- Medtronic Asks Fed. Circ. To Nix Edwards' $74M IP Award
- CHS Scrubs Hospital Buyout Amid FTC Review
- Novo Pays PE Firm $708M For Stake In Chr. Hansen
- FDA Advisers On Yaz Had Ties To Bayer: Ex-Agency Chief
- States Challenge Medicaid Expansion In Supreme Court
- 5th Circ. Lifts Injunction On Texas Fetal Sonogram Law
- Consumers Renew $29B Express Scripts, Medco Deal Fight
- FDA's Social Media Guidance Skirts Questions Of Liability
- CooperVision Hit With Investor Suit Over Lens Recall
- UCLA Still Silent On Data Breach Class Action
- Boehringer Blood Thinner Linked To Heart Attacks: Study
- SEC Adds New Suit To Ex-Wellcare CEO's Legal Woes
- Vytorin Derivative Suit Settlement Wins Initial Nod
- Judge Severs Charges Against Former Stryker Head
- Calif. County's Sherman Act Claim Nixed In Plasma MDL
- Streck Scores 2nd Fed. Circ. Win In Hematology IP Fight
- Weil Reps Sanofi On $125M Biotech Venture With VCs
- Partnering With The Feds For IP Enforcement: Part 1
- Carlton Fields Expands With Bankruptcy, Health Care Hires
- Shire Hits Sandoz With 2nd Suit Over Generic Intuniv
- Conceptus Loses Injunction Bid In Contraceptive IP Fight
- Linde Boosts European Home Care Business In $749M Buy
- Fed. Circ. Upholds Life Tech Injunction In Cell Patent Row
- Novartis Issues $120M Drug Recall, Plant Suspension
- Stryker Must Face Suit Over Joint Pain Pumps: Judge
- 'Not Whether, But How' To Improve Insurance Regulation
- Olympus Sues Ex-Chair, 2 Others Over Accounting Scandal
- Bryan Cave Helps Sigma-Aldrich In $350M Deal
- SK Capital, IBA To Form $229M Medical Imaging Venture
- DOJ Mounts High Court Defense Of Health Care Reform
- Drugmaker Valeant Losing Patience In $327M Hostile Bid
- Foreign Tobacco Cos. Can't Escape $50B Suit In Ontario
- Army Lets Health Care Cos. Revive Contract Bids
- Accenture Faces Fight Over $140M Medicaid Contract
- Perkins Coie's Chicago Office Adds 2 Finance Partners
- Rite Aid Overcharges Drug Discount Plan Members: Suit
- Aisling Capital, Others Inject $48M Into Roka Bioscience
- CVS Pharmacists Dispense Wage Suit Over Travel Pay
- Philips Slaps Rival With New Defibrillator Patent Suit
- Vioxx MDL Attys Shut Out Of $950M DOJ Settlement
- Knowledge Is Power In Failure-To-Warn Claims
- Ousted Olympus CEO Sues Over Dismissal
- Genzyme Wins Restrictions On Generic Arthritis Drug Price
- A Model For Olympus Shareholder Litigation
- Doc Linking Vaccines To Autism Sues Journal For Libel
- J&J To Pay $1B To Settle Risperdal Civil Claims: Report
- Kaye Scholer Nabs Ex-Frommer Lawrence IP Pro
- Schein Buys Oak Hill's Stake In Vet Supply Unit For $155M
- FTC Judge Orders ProMedica To Sell Off St. Luke's
- Takeda, Watson Sue Mylan Over Generic Actoplus Met XR
- The Latest On Off-Label Responses
- Actavis Pays $118M To Settle Drug Pricing Claims
- FDA Restricts Antibiotic Use In Food Animals
- Former St. Luke's Phlebotomist Sues Over OT Pay
- Ex-Cephalon GC Joins Morgan Lewis Litigation Group
- Pfizer Unit's Skelaxin Pay-For-Delay Deal Illegal: Suit
- FDA Orders Bard, Others To Study Surgical Mesh Implants
- Blue Shield Pays $2M To Settle Policy Rescission Action
- ITC Denies Sanctions Bid In NuvaRing Patent Row
- Pfizer Must Pay $45M In Menopause Drug Suits: Pa. Court
- Abbott Drops Patent Claims Over Teva's Generic Simcor
- DOJ's Emphasis On FCA Cases In 2011
- J&J Investors Renew Push For CEO Liability In Recalls
- Ex-McKesson Worker Files Pay, Seating Class Action
- Drilling Out The Competition: Not If The FTC Knows
- Reed Smith Reps Essex In $118M Biologics Deal
- Calif. Court Quashes AccentCare's Arbitration Mandate
- FDA Seeks To Streamline Medical Device Approvals
- 9th Circ. Puts Lid On Actimmune Marketing Action
- 7th Circ. Cites Anna Nicole In Nixing Debtors' Appeals
- Ex-Parkway Hospital CEO Cops To Bribing NY Lawmaker
- Jones Day Adds Ex-Health Care Fraud Chief
- US Seeks Prison Time For Ex-MediSys CEO In Bribery Case
- Spire Settles With Catheter Co. Over Recall, Deal Bungle
- AstraZeneca's Symbicort Inhaler Triggers Patent Suit
- Fed. Circ. Backs $5M Cordis Award In Stent Patent Suit
- DC Circ. Snuffs Out Suit Over FDA's Ear Candle Warnings
- Real Estate Strategies For Health Care Providers
- Varian Found To Infringe University's Radiation Patent
- Regeneron Strikes Deal With Genentech To Market Eylea
- Merck Canada Sues To Block Mylan's Generic Singulair
- Black & Decker, Others To Sweep Up RI Waste Site
- Judge Scraps First Bellwether Trial In Yaz MDL